World's Best Scientists 2026 revealed!

D-Index & Metrics

Microbiology

D-Index
62
Citations
14178
World Ranking
2876
National Ranking
1143

Courtney V. Fletcher publication distribution in Microbiology in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Microbiology in 2026. The highlighted bar marks where Courtney V. Fletcher sits on this spectrum.

55–64 publications: 8 scientists 65–74 publications: 29 scientists 75–84 publications: 55 scientists 85–94 publications: 112 scientists 95–104 publications: 137 scientists 105–114 publications: 190 scientists 115–124 publications: 235 scientists 125–134 publications: 234 scientists 135–144 publications: 288 scientists 145–154 publications: 264 scientists 155–164 publications: 264 scientists 165–174 publications: 253 scientists 175–184 publications: 276 scientists 185–194 publications: 190 scientists 195–204 publications: 233 scientists 205–214 publications: 207 scientists 215–224 publications: 198 scientists 225–234 publications: 155 scientists 235–244 publications: 161 scientists 245–254 publications: 160 scientists 255–264 publications: 146 scientists 265–274 publications: 139 scientists 275–284 publications: 148 scientists 285–294 publications: 115 scientists 295–304 publications: 96 scientists 305–314 publications: 88 scientists 315–324 publications: 106 scientists 325–334 publications: 65 scientists 335–344 publications: 76 scientists 345–354 publications: 64 scientists 355–364 publications: 62 scientists 365–374 publications: 65 scientists 375–384 publications: 61 scientists 385–394 publications: 34 scientists 395–404 publications: 44 scientists 405–414 publications: 36 scientists 415–424 publications: 35 scientists 425–434 publications: 29 scientists 435–444 publications: 33 scientists 445–454 publications: 34 scientists 455–464 publications: 25 scientists 465–474 publications: 26 scientists 475–484 publications: 20 scientists 485–494 publications: 19 scientists 495–504 publications: 16 scientists 505–514 publications: 17 scientists 515–524 publications: 23 scientists 525–534 publications: 14 scientists 535–544 publications: 14 scientists 545–554 publications: 18 scientists 555–564 publications: 12 scientists 565–574 publications: 7 scientists 575–584 publications: 9 scientists 585–594 publications: 9 scientists 595–604 publications: 9 scientists 605–614 publications: 7 scientists 615–624 publications: 9 scientists 625–634 publications: 7 scientists 635–644 publications: 4 scientists 645–654 publications: 5 scientists 655–664 publications: 6 scientists 665–674 publications: 7 scientists 675–678 publications: 3 scientists 679+ publications: 99 scientists
55 publications 679+

This scientist: 269 publications — 70th percentile

70% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 679 publications or more.

Courtney V. Fletcher D-index placement in Microbiology in 2026

The chart shows the D-index (discipline H-index) distribution of Microbiology scientists ranked by Research.com in 2026. The highlighted bar marks where Courtney V. Fletcher sits on this spectrum.

40 D-Index: 30 scientists 41 D-Index: 86 scientists 42 D-Index: 90 scientists 43 D-Index: 117 scientists 44 D-Index: 122 scientists 45 D-Index: 123 scientists 46 D-Index: 108 scientists 47 D-Index: 110 scientists 48 D-Index: 106 scientists 49 D-Index: 109 scientists 50 D-Index: 129 scientists 51 D-Index: 111 scientists 52 D-Index: 116 scientists 53 D-Index: 127 scientists 54 D-Index: 134 scientists 55 D-Index: 134 scientists 56 D-Index: 111 scientists 57 D-Index: 136 scientists 58 D-Index: 162 scientists 59 D-Index: 151 scientists 60 D-Index: 139 scientists 61 D-Index: 122 scientists 62 D-Index: 126 scientists 63 D-Index: 144 scientists 64 D-Index: 109 scientists 65 D-Index: 103 scientists 66 D-Index: 124 scientists 67 D-Index: 112 scientists 68 D-Index: 103 scientists 69 D-Index: 131 scientists 70 D-Index: 93 scientists 71 D-Index: 93 scientists 72 D-Index: 96 scientists 73 D-Index: 92 scientists 74 D-Index: 80 scientists 75 D-Index: 66 scientists 76 D-Index: 87 scientists 77 D-Index: 60 scientists 78 D-Index: 73 scientists 79 D-Index: 59 scientists 80 D-Index: 57 scientists 81 D-Index: 55 scientists 82 D-Index: 47 scientists 83 D-Index: 77 scientists 84 D-Index: 50 scientists 85 D-Index: 45 scientists 86 D-Index: 42 scientists 87 D-Index: 41 scientists 88 D-Index: 32 scientists 89 D-Index: 38 scientists 90 D-Index: 35 scientists 91 D-Index: 34 scientists 92 D-Index: 27 scientists 93 D-Index: 26 scientists 94 D-Index: 33 scientists 95 D-Index: 22 scientists 96 D-Index: 37 scientists 97 D-Index: 22 scientists 98 D-Index: 21 scientists 99 D-Index: 22 scientists 100 D-Index: 30 scientists 101 D-Index: 16 scientists 102 D-Index: 20 scientists 103 D-Index: 17 scientists 104 D-Index: 19 scientists 105 D-Index: 16 scientists 106 D-Index: 19 scientists 107 D-Index: 18 scientists 108 D-Index: 14 scientists 109 D-Index: 10 scientists 110 D-Index: 9 scientists 111 D-Index: 7 scientists 112 D-Index: 11 scientists 113 D-Index: 6 scientists 114 D-Index: 15 scientists 115 D-Index: 10 scientists 116 D-Index: 12 scientists 117 D-Index: 7 scientists 118 D-Index: 10 scientists 119 D-Index: 10 scientists 120 D-Index: 11 scientists 121 D-Index: 2 scientists 122 D-Index: 7 scientists 123 D-Index: 12 scientists 124 D-Index: 5 scientists 125 D-Index: 9 scientists 126 D-Index: 6 scientists 127+ D-Index: 95 scientists
40 D-Index 127+

This scientist: 62 D-Index — 49th percentile

49% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 127 D-Index or more.

Research.com Recognitions

  • 2015 - Fellow of the American Association for the Advancement of Science (AAAS)

Overview

Courtney V. Fletcher is affiliated with the University of Nebraska Medical Center in the United States. Their principal field of study is Medicine, with significant contributions in Infectious Diseases, Virology, Epidemiology, Neurology, and Emergency Medicine.

Their research encompasses a broad range of topics, including:

  • SARS-CoV-2 and COVID-19 Research
  • COVID-19 Clinical Research Studies
  • HIV Research and Treatment
  • HIV/AIDS drug development and treatment
  • HIV/AIDS Research and Interventions
  • HIV-related health complications and treatments
  • Long-Term Effects of COVID-19

Among recent publications attributed to this researcher are:

  • "Selective Decay of Intact HIV-1 Proviral DNA on Antiretroviral Therapy," 2020, The Journal of Infectious Diseases
  • "HIV-1 Integrase Inhibitors: A Comparative Review of Efficacy and Safety," 2020, Drugs
  • "Safety and virologic impact of the IL-15 superagonist N-803 in people living with HIV: a phase 1 trial," 2022, Nature Medicine
  • "Treatment of advanced AIDS-associated Kaposi sarcoma in resource-limited settings: a three-arm, open-label, randomised, non-inferiority trial," 2020, The Lancet
  • "Symptom and Viral Rebound in Untreated SARS-CoV-2 Infection," 2023, Annals of Internal Medicine

Frequent coauthors collaborating with this scientist include:

  • Michael D. Hughes
  • Eric S. Daar
  • Judith S. Currier
  • Joseph J. Eron
  • Anthony T. Podany

Publication venues where this researcher frequently contributes are:

  • UNC Libraries
  • bioRxiv (Cold Spring Harbor Laboratory)
  • The Journal of Infectious Diseases
  • Journal of Antimicrobial Chemotherapy
  • Clinical Infectious Diseases

Their scholarly output also includes books, notably one published through Lexington Books titled "Communicating in the Anthropocene" (2021).

Courtney V. Fletcher was recognized as a Fellow of the American Association for the Advancement of Science (AAAS) in 2015.

Best Publications

  • Persistent HIV-1 replication is associated with lower antiretroviral drug concentrations in lymphatic tissues

    Courtney V. Fletcher;Kathryn Staskus;Stephen W. Wietgrefe;Meghan Rothenberger

  • Persistent HIV-1 replication maintains the tissue reservoir during therapy

    Ramon Lorenzo-Redondo;Helen R. Fryer;Trevor Bedford;Eun Young Kim

  • Workshop on HIV Infection and Aging: What Is Known and Future Research Directions

    Rita B. Effros;Courtney V. Fletcher;Kelly Gebo;Jeffrey B. Halter

  • Defining total-body AIDS-virus burden with implications for curative strategies

    Jacob D. Estes;Cissy Kityo;Francis Ssali;Louise Swainson

  • One Month of Rifapentine plus Isoniazid to Prevent HIV‐Related Tuberculosis

    Unknown

  • Large number of rebounding/founder HIV variants emerge from multifocal infection in lymphatic tissues after treatment interruption

    Meghan K Rothenberger;Brandon F. Keele;Stephen W Wietgrefe;Courtney V. Fletcher

  • Ganciclovir treatment of cytomegalovirus disease in transplant recipients and other immunocompromised hosts.

    Erice A;Jordan Mc;Chace Ba;Fletcher C

  • Use of intravitreal ganciclovir (dihydroxy propoxymethyl guanine) for cytomegalovirus retinitis in a patient with AIDS.

    Keith Henry;Herbert Cantrill;Courtney Fletcher;Barbara J. Chinnock

  • Combination Therapy with Efavirenz, Nelfinavir, and Nucleoside Reverse-Transcriptase Inhibitors in Children Infected with Human Immunodeficiency Virus Type 1

    Stuart E. Starr;Courtney V. Fletcher;Stephen A. Spector;Florence H. Yong

  • Pharmacogenetics of Plasma Efavirenz Exposure after Treatment Discontinuation: An Adult AIDS Clinical Trials Group Study

    Heather J. Ribaudo;David W. Haas;Camlin Tierney;Richard B. Kim

  • The Effect of Lopinavir/Ritonavir on the Renal Clearance of Tenofovir in HIV‐infected Patients

    JJ Kiser;ML Carten;CL Aquilante;PL Anderson

  • Therapeutic drug monitoring in HIV infection: current status and future directions.

    David J. Back;Giorgio Gatti;Courtney Fletcher;Rodolphe Garaffo

  • Indinavir concentrations and antiviral effect.

    Edward P. Acosta;Keith Henry;Leslie Baken;Linda M. Page

  • Single-dose safety, pharmacology, and antiviral activity of the human immunodeficiency virus (HIV) type 1 entry inhibitor PRO 542 in HIV-infected adults

    Jeffrey M. Jacobson;Israel Lowy;Courtney V. Fletcher;Tobias J. O'Neill

  • Human pharmacokinetics of the antiviral drug DHPG

    Courtney Fletcher;Ronald Sawchuk;Barbara Chinnock;Paulo de Miranda

  • A randomized, open-label study to evaluate the safety and pharmacokinetics of human hepatitis C immune globulin (Civacir) in liver transplant recipients

    Gary L. Davis;David R. Nelson;Norah Terrault;Timothy L. Pruett

  • Updated guideline to perform therapeutic drug monitoring for antiretroviral agents.

    C.J.L. la Porte;D. Back;T. Blaschke;C.A.B. Boucher

  • Pharmacogenetic characteristics of indinavir, zidovudine, and lamivudine therapy in HIV-infected adults: a pilot study.

    Peter L. Anderson;Jatinder Lamba;Christina L. Aquilante;Erin Schuetz

  • Clinical and genetic determinants of intracellular tenofovir diphosphate concentrations in HIV-infected patients

    Jennifer J Kiser;Christina L Aquilante;Peter L Anderson;Tracy M King

  • Concentration-controlled compared with conventional antiretroviral therapy for HIV infection.

    Courtney V. Fletcher;Peter L. Anderson;Thomas N. Kakuda;Timothy W. Schacker

  • Antiviral dynamics and sex differences of zidovudine and lamivudine triphosphate concentrations in HIV-infected individuals.

    Peter L. Anderson;Thomas N. Kakuda;Sagar Kawle;Courtney V. Fletcher

  • Zidovudine triphosphate and lamivudine triphosphate concentration-response relationships in HIV-infected persons.

    Courtney V. Fletcher;Sagar P. Kawle;Thomas N. Kakuda;Peter L. Anderson

  • Antiviral Activity of Lamivudine in Salvage Therapy for Multidrug-Resistant HIV-1 Infection

    Thomas B. Campbell;Nancy S. Shulman;Steven C. Johnson;Andrew R. Zolopa

  • Overcoming pharmacologic sanctuaries.

    Theodore J. Cory;Timothy W. Schacker;Mario Stevenson;Courtney V. Fletcher

  • Nucleoside reverse transcriptase inhibitor-induced mitochondrial toxicity as an etiology for lipodystrophy

    Thomas N. Kakuda;Richard C. Brundage;Peter L. Anderson;Courtney V. Fletcher

Frequent Co-Authors

Edward P. Acosta
Edward P. Acosta University of Alabama at Birmingham
Timothy W. Schacker
Timothy W. Schacker University of Minnesota
Peter L. Anderson
Peter L. Anderson University of Colorado Anschutz Medical Campus
David Back
David Back University of Liverpool
Anton Pozniak
Anton Pozniak London School of Hygiene & Tropical Medicine
Henry H. Balfour
Henry H. Balfour University of Minnesota
Brian Gazzard
Brian Gazzard St Bartholomew's Hospital
Richard Haubrich
Richard Haubrich University of California, San Diego
Cavan S. Reilly
Cavan S. Reilly University of Minnesota
Keith Henry
Keith Henry Hennepin County Medical Center

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Studying Microbiology opens doors to diverse career paths, especially when complemented by online education options. For individuals seeking flexible learning opportunities, exploring online degrees for felons can be a great way to build credentials without traditional barriers.

Career options tied to microbiology often intersect with healthcare roles. For example, becoming a functional medicine nurse practitioner is a viable path that combines scientific knowledge with patient care. Microbiology knowledge enhances understanding of infections, immunity, and overall health management in such roles.

Other complementary careers include health information-related professions. Roles like certified professional coder or health information manager salary entry-level positions underline the increasing importance of medical data accuracy and management in healthcare, where microbiology data often plays a critical role.

By integrating microbiology with these related online degrees and career paths, students can enhance their employability and adapt to evolving healthcare landscapes.

Best Scientists Citing Courtney V. Fletcher

Trending Scientists